Mifepristone-misoprostol medical abortion: Home administration of misoprostol in Guadeloupe

Contraception

Volumn 60, Issue 3, 1999, Pages 167-172

  Guengant, Jean Pierre ^a   Bangou, Jacques ^b   Elul, Batya ^c   Ellertson, Charlotte ^d  

^a ORSTOM (Inst Francais Rech Pour D   (Nigeria)

^b Assoc Plan Familial de Guadeloupe   (Guadeloupe)

^c POPULATION COUNCIL   (United States)

^d Population Council   (Mexico)

Author keywords

Guadeloupe; Medical abortion; Mifepristone; Misoprostol

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ADULT; AMENORRHEA; ARTICLE; BLEEDING; CLINICAL PROTOCOL; CLINICAL TRIAL; DEVELOPING COUNTRY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GUADELOUPE; HOME CARE; HUMAN; INDUCED ABORTION; MAJOR CLINICAL STUDY; MEDICAL CARE; METHODOLOGY; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; TECHNIQUE; VOMITING;

EID: 0032763018     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(99)00074-8     Document Type: Article

References (17)

1. Grimes D. Medical abortion in early pregnancy a review of the evidence . Obstet Gynecol. 89:1997;790-796.
2. Peyron R., Aubény E., Targosz V., et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med. 328:1993;1509-1513.
3. Winikoff B., Sivin I., Coyaji K.J., et al. Safety, efficacy, and acceptability of medical abortion in China, Cuba and India a comparative trial of mifepristone-misoprostol versus surgical abortion . Am J Obstet Gynecol. 176:1997;431-437.
4. Schaff E.A., Stadalius L.S., Eisinger S.H., Franks P. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion. J Fam Pract. 44:1997;353-360.
5. Aubény E., Peyron R., Turpin C.L., et al. Termination of early pregnancy (up to and after 63 days of amenorrhea) with mifepristone (RU486) and increasing doses of misoprostol. Int J Fertil Menopausal Stud. 40:1995;85-91.
6. Termination of pregnancy with reduced does of mifepristone. Br Med J. 307:1993;532-537.
7. Winikoff B., Ellertson C., Elul B., Sivin I. Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol results of a large multicenter trial in the United States . Arch Fam Med. 7:1998;360-366.
8. Winikoff B, Sivin I, Coyaji KJ, et al. The acceptability of medical abortion in China, Cuba and India. Int Fam Plann Perspect 1997;23:73-8,89.
9. Schaff E.A., Eisinger S.H., Franks P., Kim S.S. Combined methotrexate and misoprostol for early induced abortion. Arch Fam Med. 4:1995;774-779.
10. Creinin M.D., Vittinghoff E., Galbraith S., Klaisle C. A randomized trial comparing misoprostol three and seven days after methotrexate for early abortion. Am J Obstet Gynecol. 173:1995;1578-1584.
11. Wiebe E.R. Abortion induced with methotrexate and misoprostol. Can Med Assoc J. 154:1996;165-170.
12. Bangou J, Guengant JP. RU 486/Misoprostol (3/2+1) in Guadeloupe. 39th Annual Meeting of the Commonwealth Caribbean Medical Research Council, Jamaica; April 1994.
13. INSEE and Caisse d'Allocations Familiales de la Guadeloupe. Familles de Guadeloupe. Paris, 1997.
14. Bangou J. Presentation at the Caribbean Family Planning Association. Guadeloupe; July 1997.
15. Spitz I., Bardin W., Benton L., Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med. 338:1998;1241-1247.
16. Winikoff B., Ellertson C., Clark S. Analysis of failure in medical abortion. Contraception. 54:1996;323-327.
17. Ellertson C., Elul B., Winikoff B. Can women use medical abortion with less medical supervision? Rep Health Matters. 9:1997;149-161.